MoonLake Immunotherapeutics (MLTX) Misses Q1 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: MLTX) | Delayed: 12.29 +0.36 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.93 | 52 Week High | $ | |||
| Open | $11.87 | 52 Week Low | $ | |||
| Day High | $12.38 | P/E | N/A | |||
| Day Low | $11.71 | EPS | $ | |||
| Volume | 851,803 | |||||
